Non-small cell lung cancer.

Published

Journal Article

Most patients with non-small cell lung cancer (NSCLC) are diagnosed with advanced cancer. These guidelines only include information about stage IV NSCLC. Patients with widespread metastatic disease (stage IV) are candidates for systemic therapy, clinical trials, and/or palliative treatment. The goal is to identify patients with metastatic disease before initiating aggressive treatment, thus sparing these patients from unnecessary futile treatment. If metastatic disease is discovered during surgery, then extensive surgery is often aborted. Decisions about treatment should be based on multidisciplinary discussion.

Full Text

Duke Authors

Cited Authors

  • Ettinger, DS; Akerley, W; Borghaei, H; Chang, AC; Cheney, RT; Chirieac, LR; D'Amico, TA; Demmy, TL; Ganti, AKP; Govindan, R; Grannis, FW; Horn, L; Jahan, TM; Jahanzeb, M; Kessinger, A; Komaki, R; Kong, F-M; Kris, MG; Krug, LM; Lennes, IT; Loo, BW; Martins, R; O'Malley, J; Osarogiagbon, RU; Otterson, GA; Patel, JD; Pinder-Schenck, MC; Pisters, KM; Reckamp, K; Riely, GJ; Rohren, E; Swanson, SJ; Wood, DE; Yang, SC; Hughes, M; Gregory, KM; NCCN (National Comprehensive Cancer Network),

Published Date

  • October 1, 2012

Published In

Volume / Issue

  • 10 / 10

Start / End Page

  • 1236 - 1271

PubMed ID

  • 23054877

Pubmed Central ID

  • 23054877

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Language

  • eng

Conference Location

  • United States